PMP2 regulates myelin thickening and ATP production during remyelination
Glia · 2024
DOI: 10.1002/glia.24508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Jiayue Hong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, New York, USA. Hauptthemen laut MEDLINE: Myelin Sheath, Remyelination. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
It is well established that axonal Neuregulin 1 type 3 (NRG1t3) regulates developmental myelin formation as well as EGR2‐dependent gene activation and lipid synthesis. However, in peripheral neuropathy disease context, elevated axonal NRG1t3 improves remyelination and myelin sheath thickness without increasing Egr2 expression or activity, and without affecting the transcriptional activity of canonical myelination genes. Surprisingly, Pmp2 , encoding for a myelin fatty acid binding protein, is the only gene whose expression increases in Schwann cells following overexpression of axonal NRG1t3. Here, we demonstrate PMP2 expression is directly regulated by NRG1t3 active form, following proteolytic cleavage. Then, using a transgenic mouse model overexpressing axonal NRG1t3 (NRG1t3OE) and knocked out for PMP2, we demonstrate that PMP2 is required for NRG1t3‐mediated remyelination. We demonstrate that the sustained expression of Pmp2 in NRG1t3OE mice enhances the fatty acid uptake in sciatic nerve fibers and the mitochondrial ATP production in Schwann cells. In sum, our findings demonstrate that PMP2 is a direct downstream mediator of NRG1t3 and that the modulation of PMP2 downstream NRG1t3 activation has distinct effects on Schwann cell function during developmental myelination and remyelination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
- Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.
- Paul Flechsig Institute of Neuropathology, University Hospital Leipzig, Leipzig, Germany.
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, New York, USA.
ORCID-Profile: Sejal Kabre
Förderung
- NIH HHS
- NINDS NIH HHS
- NHLBI NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Hong, J., Garfolo, R., Kabre, S., Humml, C., Velanac, V., Roué, C., Beck, B., Jeanette, H., Haslam, S., Bach, M., Arora, S., Acheta, J., Nave, K. A., Schwab, M. H., Jourd'heuil, D., Poitelon, Y., & Belin, S. (2024). PMP2 regulates myelin thickening and ATP production during remyelination. Glia. https://doi.org/10.1002/glia.24508
Vancouver
Hong J, Garfolo R, Kabre S, Humml C, Velanac V, Roué C, et al. PMP2 regulates myelin thickening and ATP production during remyelination. Glia. 2024. doi:10.1002/glia.24508
BibTeX
@article{Hong2024,
author = {Hong, Jiayue and Garfolo, Rebekah and Kabre, Sejal and Humml, Christian and Velanac, Viktorija and Roué, Clémence and Beck, Brianna and Jeanette, Haley and Haslam, Sarah and Bach, Martin and Arora, Simar and Acheta, Jenica and Nave, Klaus-Armin and Schwab, Markus H and Jourd'heuil, David and Poitelon, Yannick and Belin, Sophie},
title = {PMP2 regulates myelin thickening and ATP production during remyelination},
journal = {Glia},
year = {2024},
doi = {10.1002/glia.24508}
}
EUVIMED